Next Article in Journal
Febrile Illness of Bacterial Etiology in a Public Fever Hospital in Egypt: High Burden of Multidrug Resistance and WHO Priority Gram Negative Pathogens
Previous Article in Journal
Immunization Status of Children 1–5 Years Old Seen at the Emergency Pediatric Unit of a Teaching Hospital in North-Central Nigeria
 
 
GERMS is published by MDPI from Volume 15 Issue 4 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with the former publisher Infection Science Forum.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

The Renewed Threat of Vaccine-Preventable Diseases in the War-Struck European Continent

Carol Davila University of Medicine and Pharmacy Bucharest, National Institute for Infectious Diseases “Prof. Dr. Matei Balș”, No. 1 Dr Calistrat Grozovici Street, Bucharest 021105, Romania
Submission received: 1 March 2022 / Revised: 1 March 2022 / Accepted: 1 March 2022 / Published: 31 March 2022
One of the highlights of modern medicine has been the advent of safe and effective vaccines, which turned many infectious illnesses into preventable diseases. Much progress has been made in the area of prophylaxis, and the effects of successfully implemented national immunization programs were quick to show. Vaccinations have prevented at least 37 million deaths between 2000 and 2019 [1], and have led to enormous decreases in the incidence of major infectious diseases compared to the pre-vaccination era, specifically, a drop from 53.03 to 11.42 per 100,000 population for diphtheria, from 1.54 to 0.39 per 100,000 for tetanus, from 42.79 to 3.97 per 100,000 for pertussis, from 5.23 to 0.06 per 100,000 for poliomyelitis, and from 183.16 to 5.93 per 100,000 for measles [2].
However, the impact of vaccination on the epidemiology of infectious diseases can only be seen when a certain threshold of herd immunity is met, and this target is different for each infectious agent, as it is dependent on the route of transmission and the index of transmissibility for each pathogen. For instance, for diphtheria, which has a relatively low basic reproduction number (R0), of 4–5, the critical vaccination coverage is 79–84% while for pertussis, which has a high R0 of 10–18, coverage should be 95–99% to effectively contain the disease [3]. When these vaccine coverage targets are not met, we are faced with a risk of resurgence of these important pathogens.
With the current military conflict in Ukraine, vaccine-preventable diseases now present a renewed threat to the European continent, as highlighted by the European Centre for Disease Prevention and Control (ECDC) [4]. Medical services have been importantly impacted in war-struck Ukraine, and routine childhood immunizations have been put on hold as the main focus is now on seeking safe shelter or securing urgent medical care.
With the most recent vaccine coverage rates in Ukraine being reported as suboptimal for pertussis (81.3%), measles (81.9%) and COVID-19 (35.0%), and high numbers of cases reported each year in the country for each of these infections (Table 1), the risk of resurgence during the military conflict of vaccine-preventable diseases is quite real, with potential outbreaks being imminent either locally or in populations displaced to other European countries, which may or may not have met their own vaccination coverage targets.
For example, Ukraine has reported two cases of vaccine-derived polio virus type 2 in October 2021 [4], with an immunization catch-up campaign for children 6 months to 6 years of age planned to start on 01 February 2022, but halted by the beginning of the military conflict that same month [5].
Based on a thorough risk analysis, the ECDC has prepared a list of key vaccinations to be offered to Ukrainian refugees in the absence of documented evidence of prior vaccination. The ECDC prioritizes vaccination against COVID-19, measles-mumps-rubella and diphtheria-tetanus-pertussis-poliomyelitis-Haemophilus influenzae b, and further recommends vaccination against hepatitis B, meningococcal disease, pneumococcal disease, varicella, influenza, and tuberculosis [4].
Romania, along with many European countries, has put in place the mechanisms needed to offer free medical care to all people displaced from Ukraine, and this includes access to age-appropriate vaccinations. However, vaccine hesitancy has long hindered efforts to sustain adequate vaccination rates in many countries worldwide [11], and Romania is not an exception, with only 55.1% of parents having good knowledge regarding vaccination of their children [12], and a rate of vaccine hesitancy reported at 30.3%, with 11.7% vaccine refusal [13], which placed the country itself at suboptimal vaccine coverage (Table 1).
This highlights the need for targeted interventions to educate the general population regarding the safety and efficacy of approved vaccines, to directly address vaccine hesitancy in a language and with information that is adequate to each person’s level of understanding, and to extend these services to displaced populations whenever needed, in order to increase the acceptability of planned catch-up vaccination campaigns, and to contain the potential spread of vaccine-preventable diseases as more and more people are being impacted by military conflict.

Funding

None to declare.

Conflicts of interest

None to declare.

References

  1. Lindstrand, A.; Cherian, T.; Chang-Blanc, D.; Feikin, D.; O’Brien, K.L. The world of immunization: Achievements, challenges, and strategic vision for the next decade. J Infect Dis. 2021, 224 (Suppl. 2), S452–S467. [Google Scholar] [CrossRef] [PubMed]
  2. Pezzotti, P.; Bellino, S.; Prestinaci, F.; et al. The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900–2015. Vaccine 2018, 36, 1435–1443. [Google Scholar] [CrossRef] [PubMed]
  3. Plans-Rubió, P. Evaluation of the establishment of herd immunity in the population by means of serological surveys and vaccination coverage. Hum Vaccin Immunother. 2012, 8, 184–188. [Google Scholar] [CrossRef] [PubMed]
  4. European Centre for Disease Prevention and Control. Operational Public Health Considerations for the Prevention and Control of Infectious Diseases in the Context of Russia’s Aggression Towards Ukraine; 8 March 2022; ECDC: Stockholm, 2022. [Google Scholar]
  5. World Health Organization. 2022. Catch-up polio immunization campaign to begin in Ukraine. Available online: https://www.who.int/europe/news/item/27-01-2022-catch-up-polio-immunization-campaign-to-begin-in-ukraine (accessed on 31 March 2022).
  6. Burki, T.K. Omicron variant and booster COVID-19 vaccines. Lancet Respir Med. 2022, 10, e17. [Google Scholar] [CrossRef] [PubMed]
  7. Hodgson, D.; Flasche, S.; Jit, M.; et al. The potential for vaccination-induced herd immunity against the SARS-CoV-2 B. 1.1.7 variant. Euro Surveill. 2021, 26, 2100428. [Google Scholar] [CrossRef] [PubMed]
  8. Liu, H.; Zhang, J.; Cai, J.; et al. Herd immunity induced by COVID-19 vaccination programs and suppression of epidemics caused by the SARS-CoV-2 Delta variant in China. Version 2. medRxiv 2021. [Google Scholar] [CrossRef]
  9. Centrul Național de Supraveghere și Control al Bolilor Transmisibile. Analiza Rezultatelor Estimării Acoperirii Vaccinale la Vârsta de 18 Luni Pentru Copiii Născuți în Luna Iulie 2019; Centrul Național de Supraveghere și Control al Bolilor Transmisibile: București, 2021. [Google Scholar]
  10. Platforma Națională de Informare cu Privire la Vaccinarea Împotriva COVID-19. 2022 Situația Vaccinării în România. Available online: https://vaccinare-covid.gov.ro/situatia-vaccinarii-in-romania/ (accessed on 31 March 2022)).
  11. Stein, R.A.; Ometa, O.; Broker, T.R. COVID-19: The pseudo-environment and the need for a paradigm change. Germs 2021, 11, 468–477. [Google Scholar] [CrossRef] [PubMed]
  12. Miron, V.D.; Toma, A.R.; Filimon, C.; Bar, G.; Craiu, M. Optional vaccines in children-knowledge, attitudes, and practices in Romanian parents. Vaccines (Basel) 2022, 10, 404. [Google Scholar] [CrossRef] [PubMed]
  13. Miko, D.; Costache, C.; Colosi, H.A.; Neculicioiu, V.; Colosi, I.A. Qualitative assessment of vaccine hesitancy in Romania. Medicina (Kaunas) 2019, 55, 282. [Google Scholar] [CrossRef] [PubMed]
Table 1. Transmissibility of key vaccine-preventable diseases and vaccine coverage rates needed to ensure continued control of disease in the European continent.
Table 1. Transmissibility of key vaccine-preventable diseases and vaccine coverage rates needed to ensure continued control of disease in the European continent.
Germs 12 00007 i001

Share and Cite

MDPI and ACS Style

Săndulescu, O. The Renewed Threat of Vaccine-Preventable Diseases in the War-Struck European Continent. GERMS 2022, 12, 7-9. https://doi.org/10.18683/germs.2022.1301

AMA Style

Săndulescu O. The Renewed Threat of Vaccine-Preventable Diseases in the War-Struck European Continent. GERMS. 2022; 12(1):7-9. https://doi.org/10.18683/germs.2022.1301

Chicago/Turabian Style

Săndulescu, Oana. 2022. "The Renewed Threat of Vaccine-Preventable Diseases in the War-Struck European Continent" GERMS 12, no. 1: 7-9. https://doi.org/10.18683/germs.2022.1301

APA Style

Săndulescu, O. (2022). The Renewed Threat of Vaccine-Preventable Diseases in the War-Struck European Continent. GERMS, 12(1), 7-9. https://doi.org/10.18683/germs.2022.1301

Article Metrics

Back to TopTop